CLINICAL ROLE -
Takeda Pharmaceuticals America, Inc's Edarbi
The FDA approved Edarbi (azilsartan medoxomil), a new angiotensin receptor blocker, for the treatment of hypertension in adults.
Boehringer Ingelheim Pharmaceuticals' Pradaxa
Pradaxa (dabigatran etexilate) is the first oral direct thrombin inhibitor to be approved by the FDA.
Rx Product Profile: AstraZeneca and Pozen Inc's Vimovo
Vimovo (naproxen and esomeprazole magnesium) delayed-released tablets, marketed by AstraZeneca and Pozen Inc, are FDA approved for the symptomatic relief of arthritic conditions.
2 Clarke Drive Cranbury, NJ 08512